Novalife Healthcare Production Study
Novalife Healthcare Production Study
COLLEGE
(An Autonomous Institution)
Affiliated to Anna University, Chennai.
November, 2024
BONAFIDE CERTIFICATE
2
DECLARATION
my original work and has not been submitted for the award of any degree,
Date: PADMAVATHY.B
3
4
ACKNOWLEDGEMENT
Next, I would like to record my heartfelt thanks to our Head of the Department,
Dr.Venkat SSR Muramalla, MBA, MPhil, PhD. for encouraging and
supporting me to undertake this internship.
PADMAVATHY B
5
TABLE OF CONTENTS
II INDUSTRY PROFILE 12
5.1 Summary
5.2 Conclusion
6
CHAPTER 1
❖ Nova life Healthcare is counted amongst the prestigious and successful companies of
the industry due to the supervision and guidance of Mr. Jitesh Gadiya who is the reputed
Managing Director of the company.
❖ He is highly experienced and knowledgeable in his respective domain which helps him
to run the entire business systematically and smoothly with achieving the target goals
and objectives.
❖ Moreover, he motivates the entire workforce to work hard and complete the given task
on time with achieving the target objectives.
Vision:
Their vision is to serve communities as the premier provider of adult rehabilitation
care, resulting in the highest level of independence for their patients1.
Values:
❖ Deliver superior quality care in all that they do.
❖ Treat others as they would like to be treated.
❖ Be results-oriented and achieve objectives.
❖ Be team players.
❖ Be resourceful in overcoming obstacles.
7
FUTURE GOALS
Nova Life Health Care’s future goals for 2025 likely align with broader trends in the
healthcare industry. Nova Life aims to continue its growth by nurturing opportunities,
applying innovative ideas for business improvement, and expanding its effective marketing
network to meet high performance standards.
• Technological Integration: Embrace advanced technologies like AI, machine
learning, and IoT to enhance predictive analytics and automate decision-making
processes.
• Quality and Compliance: Maintain rigorous quality control measures and adhere to
regulatory standards such as GMP to ensure product safety and efficacy.
• Sustainability: Implement sustainable practices, including reducing carbon footprint
and using renewable energy sources.
• Market Expansion: Expand distribution channels and strengthen market presence in
more cities and regions.
8
inventory management. It suggests strategies like advanced analytics, lean
manufacturing, and robust quality management systems to overcome these challenges.
• Highlights the role of technology in enhancing pharmacy operations, including the use
of Pharmacy Management Systems (PMS), Electronic Health Records (EHR), and
automated dispensing systems to improve efficiency and accuracy.
• Aims to continue its growth by nurturing opportunities, applying innovative ideas for
business improvement, and expanding its effective marketing network to meet high
performance standards.
9
systems in place to ensure that products meet regulatory standards and are safe for
consumption.
3. To Study Inventory Management Practices: Investigate the company’s inventory
management practices to optimize stock levels, reduce waste, and prevent shortages in the
supply chain.
4. To Explore Regulatory Compliance: Understand how the operations department ensures
compliance with industry regulations and standards, identifying potential areas for risk
mitigation.
5. To Enhance Process Innovation: Identify opportunities for process innovation within the
operations department to streamline production cycles and increase overall productivity.
6. To Examine Supply Chain Resilience: Assess the resilience of the supply chain to handle
disruptions, such as raw material shortages, to improve the company’s adaptability and
responsiveness.
7. To Improve Customer Satisfaction: Explore the relationship between operational efficiency
and customer satisfaction by ensuring timely and quality product delivery.
8. To Foster Sustainability: Investigate sustainable practices within operations, such as
reducing waste and energy use, to align with environmental goals and reduce the company’s
carbon footprint.
10
CHAPTER 2
INDUSTRIAL PROFILE
The pharmaceutical industry involves the research, development, production, and distribution
of drugs and therapies aimed at treating diseases and improving health.
It is one of the most regulated sectors globally due to its impact on public health and safety.
Companies in this industry range from large, multinational corporations (like Pfizer, Merck,
and Novartis) to small, specialized biotech firms.
Key Segments
o Branded Drugs: High-revenue segment dominated by patented drugs, developed
through rigorous R&D.
o Generic Drugs: Off-patent drugs that provide more affordable alternatives and drive
competition.
o Biologics and Biosimilars: Complex, protein-based drugs often derived from living
organisms, with biosimilars emerging as competitive options post-patent expiration.
o Over-the-Counter (OTC) Medicines: Non-prescription drugs that provide revenue
diversification.
Research and Development (R&D)
• R&D is critical, with companies investing heavily to innovate new treatments. It
includes preclinical research, clinical trials, and regulatory approval.
• Clinical trials are lengthy and costly, and only a small percentage of drugs in
development make it to market.
• Companies often collaborate with research institutions, universities, or other firms to
share costs and expertise.
Market Drivers
o Aging Population: Increases in chronic diseases like diabetes, cancer, and
11
affect timelines and costs, especially for new drugs.
o Intellectual Property (IP) and Patent Expirations: Loss of patent protection can lead to
generic competition, impacting revenue.
o High R&D Costs and Failure Rates: Many drugs fail in trials, making drug
development expensive and risky.
o Pricing Pressures: Rising scrutiny from governments and consumers on drug pricing
affects profitability, particularly in the U.S. market.
Trends and Innovations
o Focus on Rare Diseases: Orphan drugs for rare diseases provide high returns due to
Digital Health and AI: AI is used in drug discovery, data analysis, and personalized
medicine to streamline R&D.
o Mergers and Acquisitions (M&A): Companies pursue M&As to expand their product
portfolios, enter new markets, and leverage specialized demand and regulatory
incentives.
o Shift Towards Value-Based Care: Pressure is increasing for drugs to demonstrate
efficacy and cost-effectiveness in real-world scenarios.
Global Market Outlook
o The pharmaceutical market is expected to grow, driven by emerging markets, the
demand for innovative treatments, and advancements in healthcare
o Developing regions like Asia-Pacific and Latin America offer new opportunities due
to improving healthcare infrastructure and growing economies.
Major Players
o Key players include large multinational corporations (e.g., Johnson & Johnson,
Roche, Sanofi), which lead in sales, R&D, and market influence.
o Small biotech firms also play an essential role in innovation, often targeting specific
niches or developing initial-stage treatments that larger companies may acquire.
Future Outlook
o Growth is expected in areas like oncology, immunology, and neuroscience due to
unmet needs.
o Increasing competition from biosimilars and generics will pressure profit margins.
o The role of technology in drug discovery and delivery is expected to continue
evolving, potentially reducing development timelines.
o The pharmaceutical industry is both highly profitable and highly volatile, with
immense investment in R&D offset by regulatory risks and public scrutiny
12
CHAPTER 3
COMPANY PROFILE
INTRODUCTION
At Novalife, we always believe that great businesses are the results of great
partnerships. For the same reason, we place high value in every customer and his needs and
work endlessly upon building a good rapport with each one of them. Perhaps, this paradigm
of placing our customers first has enabled us to penetrate the domestic market successfully in
a very short span of time. Sharing strong bond with the customers, attending to their needs
diligently and healthy mutual growth leading is what we strive to achieve at Nova life
Nova life Healthcare is counted amongst the prestigious and successful
companies of the industry due to the supervision and guidance of Mr. Jitesh Gadiya who is
the reputed Managing Director of the company. He is highly experienced and knowledgeable
in his respective domain which helps him to run the entire business systematically and
smoothly with achieving the target goals and objectives. Moreover, he motivates the entire
workforce to work hard and complete the given task on time with achieving the target
objectives.
Quality is the hallmark of Nova life. Finest quality has known to be synonymous
with our products. Right from the inception stages, quality has found a profound place in all
our endeavours.
At every phase of manufacturing, right from raw materials to finished products,
highest standard of quality is ensured with the help of most modern equipment, trained
personnel and state-of-the-art manufacturing facilities. All production facilities match highest
standards of hygiene and with all equipment’s undergoing periodic inspection from time to
time for consistency from batch to batch, the odds of defects are literally zeroed down. Our
manufacturing facilities are certified by WHO GMP certified. At Nova life, we live by the
highest standards of ethics and have a steadfast commitment to customer satisfaction.
We are an award winning, fast growing and quality certified pharma company
based in Bangalore. We are committed to reform healthcare in India and are flagbearers of
ethical business practices.
o Nurture growth opportunities to enable growth with the passage of every single day
o Build an effective marketing network to serve the needs of a medical profession
o ISet and meet high standards of performance
13
Key Features of a Reliable Pharma Franchise
o Certifications, Accreditations and Licenses: WHO-GMP, ISO 1:2015 and FSSAI
quality certified. Quality is the hallmark of Nova life. • Product Range: Widest range
of 350+ products. One-stop solution for all your product needs
o Monopoly: We provide monopoly based exclusive rights to our partners for marketing
your own products manufactured by us
o Promotional Material: We provide Visual-aids, MR bags, Literatures, LBL’s and
other marketing support to help you achieve your desired sales targets
o Manufacturing Plant: Own manufacturing unit. If you choose us, you're getting
productsat better margins and max savings, direct-from-manufacturer
o Regulatory Authority Approvals: All products DCGI/DPCO approved
o Packaging: No damages to packaging during transit time. We provide leakage proof
and damage resistance packaging & delivery
o Timely Delivery: We are a commitment-based firm run by professional leaders &
managers. All products dispatched from us are delivered within committed timelines
o Market Knowledge: Well, experienced in Market Knowledge & Intelligence.
o Sales Network: Distribution channels in 40+ cities
o Pricing & Marketing: All products are priced under NPP Policy 2012 & marketed
under CAPMM Policy of Department of Pharmaceuticals, Govt of India
o Savings: Maximum savings guaranteed on bulk orders.
PRODUCT LIST
o Inflammatory, Analgesics & Anti-spasmodic
o Antacid, Anti-flatulent, Anti-emetic & Anti-ulcer ant
o Anti-biotic ▪ Anti-cold, Anti-allergic & Cough Suppressants
o Gynae & Infertility Range
o Orthopaedic Range
o Vitamins, Minerals, Proteins & Other Nutritional Supplements
14
o Derma
o Pre-Probiotics
o Steroids
o Dental Range
o Anti-diabetic
o We have an array of products on offer ranging from Antibiotics, Antacids,
Analgesics, Anti-diabetic, Cough Suppressants to Nutritional supplements. Reminder
Card is supposedly the best way to increase your chances for brand promotion
through doctors
15
o Azithromycin 250mg
ANTI-COLD, ANTI-ALLERGIC & COUGH SUPPRESSANTS
o Paracetamol 650mg
o Paracetamol 250mg Suspension
o Paracetamol Infusion IP 1.0%w/v
o Levocetirizine Hydrochloride tablets o Bilastine & Montelukast Tablets
o Montelukast 10mg + Doxophylline 400mg
o Montelukast 10mg + Levocetirizine 5mg
o Montelukast 4mg + Levocetirizine 2.5mg
o Dydrogesterone tablets 10mg
ORTHOPEDIC RANGE
o Coral Calcium & Vitamin D3 tablet
o Polmacoxib 2mg Capsules
o Diacerin 50mg + Glucosamine Sulphate 750mg + M.S.M.250mg Tabs
o Mecobalamin 750 mcg+ Glucosamine 500mg +M.S.M.250. Tabs
o Calcium Citrate 1000 mg
EYE EAR RANGE
o Carboxymethylcellulose 0.5 w/w
o Moxifloxacin Opthalmic Suspension 0.5% w/v
o Ofloxacin 0.3% Eye Drops
GYNAE & INFRTILITY RANGE
o Dydrogesterone tablets 10mg
o Dydrogal 20 Dydrogesterone tablets 10mg
o Yufit D3 Drops Dydrogesterone tablets 10mg
VITAMINS, MINERALS,PROTEINS & OTHER NUTRITIONAL
SUPPLEMENTS
o Protein powder fortified with DHA
o Digestive enzyme with B-Complex Syrup
o Liver Tonic With Double Strength
o Immunity powder Energy Drink
16
OVERVIEW FUNCTIONAL DEPARTMENT
17
Marketing
Focuses on branding, advertising, market research, public relations, and customer
engagement. To create brand awareness, drive customer demand, and generate leads to
support sales and growth
Sales
Engages with customers, manages accounts, negotiates deals, and closes sales. To
increase revenue, expand market reach, and establish strong customer relationships to ensure
business growth.
Operations
Manages production, logistics, supply chain, quality control, and inventory. To ensure
products or services are delivered efficiently and meet quality standards, optimizing cost and
time.
IT (Information Technology)
Manages technology infrastructure, cybersecurity, software development, and digital
transformation. To support organizational technology needs, enhance productivity through
digital tools, and safeguard data and systems.
Customer Service
Addresses customer inquiries, resolves issues, and provides support for products and
services. To improve customer satisfaction, retain customers, and build brand loyalty through
positive interactions.
Legal
Handles contracts, compliance, intellectual property, and litigation. To protect the
organization legally, ensure regulatory compliance, and mitigate risks.
18
ORGANIZATION CHART
19
CHAPTER IV
STUDY OBSERVATION
Novalife Healthcare may use observational studies, which are crucial in real-
world healthcare research for studying patient outcomes, treatment effectiveness, and disease
progression in natural clinical settings. These studies differ from clinical trials as they do not
involve intervention from researchers, making them ideal for gathering evidence on long-
term safety, treatment patterns, and patient behavior
There are various observational study types: cohort studies, which follow a
group over time; case-control studies, which compare patients with a condition to those
without; and cross-sectional studies, which examine a population at a single point in time.
Additionally, longitudinal studies track changes over a longer duration, and ecological studies
analyze population-level data. Observational research often faces challenges such as selection
bias, missing data, and confounding variables, which can make it difficult to determine
causality. However, methods like propensity score matching and instrumental variable
analysis help mitigate these biases to improve study reliability.
Furthermore, the integration of big data and machine learning (ML) is
transforming observational studies by enabling advanced analyses across large and varied
datasets, such as electronic health records, patient registries, and social media. ML
applications can help predict disease progression, identify subpopulations within data, and
generate real-world evidence for healthcare providers and policymakers, potentially
enhancing clinical guidelines and health policies in practical, data-driven ways.
20
staff might employ to cope with limitations in resources or processes, providing critical
insights for risk management.
Process Optimization
Through structured observations, inefficiencies in patient and equipment
flow can be identified. Tracking movements and bottlenecks in real-time allows for
adjustments in layout or process design that can speed up response times and improve patient
throughput, especially in high-demand areas like the emergency or operating rooms
21
training gaps. Ensuring that staff are proficient in the technology they use daily is essential
for both efficiency and patient safety.
Environmental Factors
Observational studies can also consider factors like noise levels, lighting, and
spatial arrangement, which can impact staff performance and patient comfort. Environmental
factors play a role in both patient satisfaction and the efficiency with which healthcare staff
can perform their duties.
Quality Control
Defect Rates: Research often highlights the correlation between effective quality
control measures and reduced defect rates, leading to lower costs and improved customer
satisfaction. Root Cause Analysis: Findings frequently indicate that implementing root cause
analysis techniques can help in addressing recurring quality issues.
22
downtime and maintenance costs.
Environmental Impact
Sustainability Practices: Findings often indicate that sustainable practices can lead
to cost savings and a better corporate image, attracting environmentally-conscious
consumers.
23
CHAPTER V
5.1. SUMMARY
The production department at Nova Life Healthcare has conducted a comprehensive study to
identify key areas for improvement and enhance overall efficiency. One of the primary
findings from this study is the importance of monitoring patient flow from admission to
discharge. By identifying bottlenecks in the care delivery process, the department can
implement strategies to optimize patient flow, reduce congestion, and ensure that patients
receive timely and effective care. This not only improves operational efficiency but also
enhances patient satisfaction and outcomes.
Resource utilization is another critical area highlighted by the study. By analyzing the usage
of equipment and beds, the department discovered instances of both underutilization and
overburden. This insight is crucial for making informed decisions about resource allocation
and investments. For example, underutilized equipment can be repurposed or relocated to
areas with higher demand, while overburdened resources may require additional support or
upgrades. Effective resource management ensures that the department operates smoothly and
can meet the needs of patients without unnecessary delays or shortages.
Task coordination within the production department has also been a focus of the study. Clear
task assignments and well-defined roles are essential for improving team efficiency and
patient outcomes. The study found that reducing miscommunications and role overlaps leads
to smoother operations and better collaboration among staff members. This, in turn, enhances
the overall quality of care provided to patients. By ensuring that each team member
understands their responsibilities and has the necessary support, the department can function
more effectively and deliver higher standards of care.
Technology integration plays a significant role in the operations of the production
department. The study emphasized the need to monitor the use of technology to identify
usability issues and training gaps. Ensuring that staff are proficient in using technological
tools is vital for improving efficiency and patient safety. For instance, automated systems for
medication dispensing or electronic health records can streamline processes and reduce the
risk of errors. However, these benefits can only be realized if staff are adequately trained and
comfortable using the technology. Addressing any gaps in training and usability can lead to
more efficient operations and better patient care.
In summary, the study conducted by the production department at Nova Life Healthcare
underscores the importance of effective production planning and control. By focusing on
patient flow, resource utilization, task coordination, and technology integration, the
department can enhance operational efficiency and maintain high standards of patient care.
These findings provide a roadmap for continuous improvement and ensure that Nova Life
Healthcare remains a leader in the healthcare industry.
24
5.2 CONCLUTION
The internship at Nova Life Healthcare’s production department provided invaluable insights
into the operational aspects of a leading pharmaceutical company. Throughout the internship,
several key areas were explored, leading to significant findings and recommendations for
future improvements. One of the primary focuses was on optimizing patient flow from
admission to discharge. By identifying and addressing bottlenecks in the care delivery
process, the department can enhance operational efficiency and ensure timely patient care.
This not only improves patient satisfaction but also contributes to better health outcomes.
The internship provided a comprehensive understanding of the production department’s
operations at Nova Life Healthcare. The findings underscore the importance of effective
production planning and control in maintaining high-quality patient care and operational
efficiency. The recommendations made during the internship can serve as a roadmap for
continuous improvement, ensuring that Nova Life Healthcare remains at the forefront of the
healthcare industry.
In conclusion, the internship experience was highly educational and provided practical
insights into the complexities of healthcare operations. The knowledge gained and the
recommendations made will contribute to the ongoing efforts to enhance the efficiency and
effectiveness of the production department at Nova Life Healthcare.
25